|
Market Closed -
CBOE
16:30:00 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.217 EUR | 0.00% |
|
0.00% | -40.37% |
| 09-09 | Evotec Initiates Phase 1 Trial of Potential Smallpox, Mpox Treatment | MT |
| 09-09 | Evotec Commences Early-stage Study of Potential Orthopoxvirus Therapy | MT |
Stock exchange
CBOE
0IRF 3.217 €
0.00%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| EVT | 2.968EUR | -2.50% | 3.57M € | ||
Tradegate
| EVT | 3.008EUR | -1.70% | 1.53M € | |
CBOE
| EVTd | 2.986EUR | -1.78% | 1.46M € | |
Boerse Muenchen
| EVT | 3.000EUR | -1.57% | 410K € | |
Börse Stuttgart
| EVT | 3.006EUR | -1.25% | 95.66K € | |
Borsa Italiana
| 1EVT | 2.986EUR | -1.78% | 50.98K € | |
Deutsche Boerse AG
| EVT | 2.974EUR | -0.87% | 15.76K € | |
Wiener Boerse
| EVT | 3.064EUR | -2.61% | 1.54K € | |
OTC Markets
| EVOTF | 3.890USD | -41.85% | 1.56K $ | |
Bulgaria S.E.
| EVT | 2.988EUR | -9.95% | 119.52 € | |
London S.E.
| 0IRF | 2.970EUR | -3.19% | 0 € | |
CBOE
| 0IRF | 3.217EUR | 0.00% | 0 € | |
Swiss Exchange
| EVT | 3.148CHF | -1.75% | 0 CHF | |
| EVO | 1.730USD | -2.26% | 73.57K $ | ||
CBOE
| EVO | 1.730USD | -1.70% | 1.88K $ | |
Deutsche Boerse AG
| EVTA | 1.290EUR | -18.87% | 0 € | |
Börse Stuttgart
| EVTA | 1.440EUR | -1.37% | 0 € | |
Boerse Muenchen
| EVTA | 1.560EUR | 0.00% | 0 € |
Quotes 5-day view: Evotec SE
Real-time CBOE| 07/09/2026 | 08/09/2026 | 09/09/2026 | 10/09/2026 | 11/09/2026 | |
|---|---|---|---|---|---|
| Last | €3.217 | €3.217 | €3.217 | €3.217 | €3.217 |
| Volume | 0 | 0 | 0 | 0 | 0 |
| Change | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Opening | €3.217 | €3.217 | €3.217 | €3.217 | €3.217 |
| High | €3.217 | €3.217 | €3.217 | €3.217 | €3.217 |
| Low | €3.217 | €3.217 | €3.217 | €3.217 | €3.217 |
Performance
| Current month | -13.61% | ||
| 1 month | -13.61% | ||
| 3 months | -37.96% | ||
| 6 months | -27.22% | ||
| Current year | -40.37% | ||
| 1 year | -45.62% | ||
| 3 years | -85.03% | ||
| 5 years | -92.60% | ||
| 10 years | -27.69% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
527,560,219
Market Cap (USD)
612,302,947
Net sales (EUR)
788,400,000
Net sales (USD)
915,041,783
Free-Float
89.91 %
Free-Float capitalization (EUR)
474,761,707
Free-Float capitalization (USD)
551,023,337
Average Daily Capital Traded
0%
Indicators
Moving average 5 days
3.217
Moving average 20 days
3.597
Moving average 50 days
3.791
Moving average 100 days
4.466
Price spread / (MMA5)
0.00%
Price spread / (MMA20)
+11.82%
Price spread / (MMA50)
+17.84%
Price spread / (MMA100)
+38.81%
RSI 9 days
6.31
RSI 14 days
14.24
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -45.62% | -85.03% | 612M | ||
| -0.71% | -6.35% | -2.99% | +9.59% | 45.48B | ||
| +0.21% | -2.98% | +337.74% | +519.55% | 43.68B | ||
| +1.74% | -2.24% | +39.82% | +20.76% | 43.09B | ||
| +1.38% | -3.28% | +6.84% | +67.62% | 39.4B | ||
| -1.44% | -5.26% | +8.97% | +39.76% | 31.91B | ||
| +0.87% | -2.60% | - | - | 17.31B | ||
| +0.75% | -0.64% | +19.75% | +110.17% | 16.4B | ||
| -0.31% | -2.78% | +10.78% | +31.02% | 14.24B | ||
| +1.93% | -3.55% | +82.00% | +41.17% | 13.28B | ||
| Average | +0.49% | -3.57% | +50.81% | +83.85% | 26.54B | |
| Weighted average by Cap. | +0.41% | -3.67% | +74.27% | +123.74% |
Historical Quotes: Evotec SE
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 3.22 | 3.22 | |
| 1 month | 3.22 | 3.72 | |
| 3 years | 3.22 | 21.51 | |
| 5 years | 3.22 | 45.4 | |
| 10 years | 3.22 | 45.4 |
Monthly variations
Annual variations
| 2026 | -40.37% | ||
| 2025 | -39.31% | ||
| 2024 | -56.51% | ||
| 2023 | +35.59% | ||
| 2022 | -63.70% | ||
| 2021 | +37.84% | ||
| 2020 | +30.38% | ||
| 2019 | +33.60% | ||
| 2018 | +27.70% | ||
| 2017 | +81.79% | ||
| 2016 | +78.90% | ||
| 2015 | +13.27% | ||
| 2014 | +0.22% | ||
| 2013 | +40.52% | ||
| 2012 | +13.77% | ||
| 2011 | -21.11% |
- Stock Market
- Stocks
- EVT Stock
- 0IRF Stock
- Quotes Evotec SE
Select your edition
All financial news and data tailored to specific country editions

















